Perampanel Hydrate
一、 Product Overview
Perampanel Hydrate is a non-competitive AMPA glutamate receptor antagonist which is developed by Eisai, indicated for treatment of partial-onset seizures with or without secondarily generalized seizures in patients. It was approved by the EMA on Jul 23, 2012
二、Main products
Description | Structural Formula | CAS No. | Category |
5'-broMo-1'-phenyl-[2,3'-bipyridin]-6'(1'H)-one |
| 381248-06-2 | intermediates |
1-Phenyl-5-(pyridin-2-yl)-1,2-dihydropyridin-2-one |
| 381725-50-4 | intermediates |
5-(2-Pyridyl)-1,2-dihydropyridin-2-one |
| 381233-78-9 | intermediates |
2-(1,3,2-dioxaborinan-2-yl)benzonitrile |
| 172732-52-4 | intermediates |
Only provide intermediates.
Note: Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes patent infringement and its liability is at buyer’s risk.